FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Amzak Capital Management, LLC

2. Date of Event Requiring Statement (MM/DD/YYYY)
3/22/2017 

3. Issuer Name and Ticker or Trading Symbol

Zosano Pharma Corp [ZSAN]

(Last)        (First)        (Middle)

980 N FEDERAL HIGHWAY SUITE 315,

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

BOCA RATON, FL 33432       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, par value of $0.0001   5151813   D   (1)  
Common Stock, par value of $0.0001   118033   I   Owned by Michael D. Kazma, manager of Amzak Capital Management, LLC  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Warrant   (1) 8/19/2016   8/26/2017   Common Stock   1095153   $1.45   D   (1)  
Series B Warrant   (1) 8/19/2016   8/19/2021   Common Stock   1095153   $1.55   D   (1)  

Explanation of Responses:
( 1)  The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a manager of the Reporting Person.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Amzak Capital Management, LLC
980 N FEDERAL HIGHWAY SUITE 315,
BOCA RATON, FL 33432

X

Kazma Michael D
980 N FEDERAL HIGHWAY SUITE 315,
BOCA RATON, FL 33432

X

Kazma Gerald J
980 N FEDERAL HIGHWAY SUITE 315,
BOCA RATON, FL 33432

X


Signatures
AMZAK CAPITAL MANAGEMENT, LLC By: /s/ Michael Kazma MICHAEL D KAZMA PRESIDENT /s/ Michael D. Kazma MICHAEL KAZMA /s/ Gerry Kazma GERRY KAZMA 3/27/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Zosano Pharma (NASDAQ:ZSAN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Zosano Pharma Charts.
Zosano Pharma (NASDAQ:ZSAN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Zosano Pharma Charts.